HibTITER

HibTITER Description

Composition
- 1 ml contains -
- Active ingredient: Haemophilus influenzae type b oligosaccharide 20 g + Diphtheria CRM197 protein 50 g (Biologic STD) ................... 70 g (Haemophilus influenzae type b Eagan (PBCC 197) strain, Corynebacterium diphtheria C7 (197) strain)
- Isotonic agent : Sodium Chloride (USP) ......................... 9mg
- Vehicle : Water for Injection (USP) ........................... q.s.

Indication
The immunization of infants and children 2 months to 71 months of age against invasive disease caused by Haemophilus influenzae type b.

Dosage and Administration
HibTITER should be injected intramuscularly, preferably into the midlateral muscles of the thigh. For infants 2 to 6 months of age, the immunizing dose is three separate injections of 0.5ml given at approximately 2-months intervals. Previously unvaccinated infants from 7 through 11 months of age should receive two separate injections approximately 2 months apart. Children from 12 through 14 months of age who have not been vaccinated previously receive one injection. All vaccinated children receive a single booster dose at 15months of age or older, but not less than 2 months after the previous dose. Previously unvaccinated children 15 to 71 months of age receive a single injection

How Supplied
0.5ml/vial x 4

HibTITER Related Resource

HibTITER Related Products

Unizedo
ne Inj (Cefazedone sodium)

UNIMED
Nagram Tab. (Nalidixic acid)

Noctaci
n Tab. (Norfloxacin)

Octacin
Tab. (Ofloxacin)

Clamyce
f Cap. (Clindamyci Hydrochloride)

Roxaid
Tab. (Roxithromycin)

Netin I
nj. (Netilmicin sulfate)

Cefxime
Tab. (Cefixime 200mg)

Adikan
Inj. (Amikacin sulfate)

HibTITER

Propoli
s Gold

CLA